Eli Lilly and Co (NYSE:LLY)
| 196.35 Delayed Data As of May 14 |  +0.14 / +0.07%Today’s Change | 129.21 Today|||52-Week Range 218.00 | +16.29% Year-to-Date |
LLY Regular Dividend: LLY began trading ex-dividend on 05/13/21. A $0.85 dividend will be paid to shareholders of record as of 05/14/21.
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 196.21 |
| Today’s open | 195.25 |
| Day’s range | 195.02 - 197.25 |
| Volume | 209 |
| Average volume (3 months) | 3,964,169 |
| Market cap | $188.2B |
Data as of 4:00pm ET, 05/14/2021
Growth & Valuation
| Earnings growth (last year) | +36.99% |
| Earnings growth (this year) | +0.27% |
| Earnings growth (next 5 years) | +12.30% |
| Revenue growth (last year) | +9.95% |
| P/E ratio | 29.4 |
| Price/Sales | 6.28 |
| Price/Book | 33.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -0.05 | -0.06% |
| NVSNovartis | +0.04 | +0.04% |
| ABBVAbbVie | -0.04 | -0.03% |
| PFEPfizer | -0.03 | -0.07% |
Data as of 7:30pm ET, 05/14/2021
Financials
| Next reporting date | August 3, 2021 |
| EPS forecast (this quarter) | $1.94 |
| Annual revenue (last year) | $24.5B |
| Annual profit (last year) | $6.2B |
| Net profit margin | 25.24% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
